[Not Available]

[无法使用]

阅读:1

Abstract

INTRODUCTION: Italy retains a unique wealth of information on drug usage, embodied in the OsMed Report, published since 2001 and based on data collected by the National Observatory on the Use of Medicines. The Report analyzes data on drug dispensing, pharmaceutical expenditure, and prescribing appropriateness; it monitors regional and temporal variations in drug use and identifies public health issues, promoting a more appropriate use of medicines. METHODS: As part of the III Edition of the Forum on Regional Pharmaceutical Policies, titled “Ensuring equitable and consistent access to pharmaceutical care while safeguarding the sustainability of the National Health Service”, a dedicated Working Group examined how Regions can apply the OsMed Report to share strategies to improve therapeutic appropriateness. RESULTS: The discussion emphasized the need for more efficient management of health data and a greater interoperability between information systems to enhance institutional responsiveness. Additionally, the Group explored the development of indicators linking pharmaceutical consumption to clinical outcomes, which could support regional planning through predictive and up to date tools. CONCLUSION: The Working Group highlighted the strengths and weaknesses of the OsMed Report, proposing solutions to make it more accessible and useful at the regional level, to promote therapeutic adherence and to improve the transparency of drug access timelines.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。